NRG1 and schizophrenia: Compared to the more established models of schizophrenia in the literature, being genetic, pharmacological or lesion, our model of using anti-Nrg1 antibodies is fairly new and less established, regarding the characterization of behavioral phenotypes, pathophysiology, responses to drugs/treatment (such as antipsychotics) and the developmental time course of the landmark events.